Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務分析

◆英語タイトル:Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4994
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report
Summary

Vertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vertex Pharmaceuticals Incorporated (Vertex or ‘the company’) is involved in the discovery, development and commercialization of new medicines, which is biotechnology company. The company operates R&D facilities in California, Washington D.C., Iowa, Canada, Switzerland, the UK, France, Germany, Australia, Ireland, Spain, Italy and the Netherlands. It offers products for cystic fibrosis (CF) treatment including Kalydeco (ivacaftor) and Orkambi (ivacaftor/lumacaftor). Vertex is involved in curing various disease including cancer, influenza, neurological diseases and disorders such as pain and cystic fibrosis.The company primarily operates in the US, Canada and Europe. It is headquartered in Boston, Massachusetts.

Scope

- Detailed information on Vertex Pharmaceuticals Incorporated required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vertex Pharmaceuticals Incorporated in the form of a SWOT analysis
- An in-depth view of the business model of Vertex Pharmaceuticals Incorporated including a breakdown and examination of key business segments
- Intelligence on Vertex Pharmaceuticals Incorporated’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vertex Pharmaceuticals Incorporated, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vertex Pharmaceuticals Incorporated and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vertex Pharmaceuticals Incorporated as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vertex Pharmaceuticals Incorporated’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Vertex Pharmaceuticals Incorporated: Company Overview
Vertex Pharmaceuticals Incorporated: Overview and Key Facts
Vertex Pharmaceuticals Incorporated: Overview
Vertex Pharmaceuticals Incorporated: Key Facts
Vertex Pharmaceuticals Incorporated: Key Employees
Vertex Pharmaceuticals Incorporated: Key Employee Biographies
Vertex Pharmaceuticals Incorporated: Major Products and Services
Vertex Pharmaceuticals Incorporated: Company History
Vertex Pharmaceuticals Incorporated: Management Statement
Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Vertex Pharmaceuticals Incorporated: Key Competitors
Vertex Pharmaceuticals Incorporated: Company Analysis
Vertex Pharmaceuticals Incorporated: Business Description
Vertex Pharmaceuticals Incorporated: SWOT Analysis
Vertex Pharmaceuticals Incorporated: SWOT Overview
Vertex Pharmaceuticals Incorporated: Strengths
Vertex Pharmaceuticals Incorporated: Weaknesses
Vertex Pharmaceuticals Incorporated: Opportunities
Vertex Pharmaceuticals Incorporated: Threats
Vertex Pharmaceuticals Incorporated: Corporate Financial Deals Activity
Vertex Pharmaceuticals Incorporated: Financial Deals Overview
Vertex Pharmaceuticals Incorporated: Targets and Partners
Vertex Pharmaceuticals Incorporated: Top Deals 2016 – 2020YTD*
Vertex Pharmaceuticals Incorporated: Advisors
Vertex Pharmaceuticals Incorporated: Top Legal Advisors
Vertex Pharmaceuticals Incorporated: Mergers and Acquisitions
Vertex Pharmaceuticals Incorporated: Corporate Venturing
Vertex Pharmaceuticals Incorporated: Partnership
Vertex Pharmaceuticals Incorporated: Recent Developments
Vertex Pharmaceuticals Incorporated: News and Events Summary
Vertex Pharmaceuticals Incorporated: Contracts
Vertex Pharmaceuticals Incorporated: Corporate Governance
Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility
Vertex Pharmaceuticals Incorporated: Financial Deals
Vertex Pharmaceuticals Incorporated: Financial Performance
Vertex Pharmaceuticals Incorporated: Regulatory and Legal Events
Vertex Pharmaceuticals Incorporated: Research & Development
Vertex Pharmaceuticals Incorporated: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Vertex Pharmaceuticals Incorporated: Key Facts
Table 2: Vertex Pharmaceuticals Incorporated: Key Employees
Table 3: Vertex Pharmaceuticals Incorporated: Company History
Table 4: Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Table 5: Vertex Pharmaceuticals Incorporated: Key Competitors
Table 6: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Vertex Pharmaceuticals Incorporated: M&A Activity by Geography (TTM*)
Table 8: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Table 10: Vertex Pharmaceuticals Incorporated: Targets and Partners
Table 11: Vertex Pharmaceuticals Incorporated: Top Deals 2016 - 2020YTD*
Table 12: Vertex Pharmaceuticals Incorporated: Legal Advisor Ranking by Value (US$m)
Table 13: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Vertex Pharmaceuticals Incorporated: M&A Activity by Geography (2016 - YTD*2020)
Table 15: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 16: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2016 - YTD*2020)
Table 17: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 18: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 19: Vertex Pharmaceuticals Incorporated: News and Events Summary
Table 20: Vertex Pharmaceuticals Incorporated: Contracts
Table 21: Vertex Pharmaceuticals Incorporated: Corporate Governance
Table 22: Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility
Table 23: Vertex Pharmaceuticals Incorporated: Financial Deals
Table 24: Vertex Pharmaceuticals Incorporated: Financial Performance
Table 25: Vertex Pharmaceuticals Incorporated: Regulatory and Legal Events
Table 26: Vertex Pharmaceuticals Incorporated: Research & Development
Table 27: Vertex Pharmaceuticals Incorporated: Strategy and Operations

★海外企業調査レポート[Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • A.H.A International Co., Ltd.:戦略・SWOT・企業財務分析
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Danske Bank A/S:企業のM&A・事業提携・投資動向
    Danske Bank A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Danske Bank A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • The Nature’s Bounty Co.:企業の戦略・SWOT・財務情報
    The Nature’s Bounty Co. - Strategy, SWOT and Corporate Finance Report Summary The Nature’s Bounty Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Fountain Biopharma Inc (4159):製薬・医療:M&Aディール及び事業提携情報
    Summary Fountain Biopharma Inc (Fountain Biopharma), a subsidiary of Microbio Co Ltd, is a developer of therapeutic monoclonal antibodies and DNA aptamers. The company’s technologies include IgE development platform, IEA’s drug development platform and tumor stem cell culture platform. Its IgE devel …
  • Asda Stores Ltd:戦略・SWOT・企業財務分析
    Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Madhya Pradesh Power Generating Company Ltd:発電所・企業SWOT分析
    Madhya Pradesh Power Generating Company Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • International AIDS Vaccine Initiative-製薬・医療分野:企業M&A・提携分析
    Summary International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. It also …
  • SOM Biotech SL:製薬・医療:M&Aディール及び事業提携情報
    Summary SOM Biotech SL (SOM Biotech) is a drug repurposing company that discovers and develops new drugs for orphan indications. The company’s pipeline products include SOM0777, SOM0226, SOM3355, SOM1201 and SOM2201 are used for the treatment of TTR amyloidosis, glioblastoma, huntington disease, duc …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Ono Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務分析
    Ono Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ono Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PEN, Inc. (PENC):企業の財務・戦略的SWOT分析
    PEN, Inc. (PENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • EnPro Industries, Inc.:企業のM&A・事業提携・投資動向
    EnPro Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnPro Industries, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Ricoh Leasing Company, Ltd.:企業の戦略・SWOT・財務情報
    Ricoh Leasing Company, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ricoh Leasing Company, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • ArmaGen Inc-製薬・医療分野:企業M&A・提携分析
    Summary ArmaGen Inc (ArmaGen), formerly ArmaGen Technologies Inc is a healthcare solution provide that discovers and develops novel therapies for the treatment of neurological disorders. The company's pipeline portfolio includes AGT-181, AGT-182, AGT-183 and AGT-184 which are used for the treatment …
  • Alliance Oil Co Ltd:企業の戦略的SWOT分析
    Alliance Oil Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • First Asset Investment Management Inc:企業の戦略的SWOT分析
    First Asset Investment Management Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Pro-Pac Packaging Ltd (PPG):企業の財務・戦略的SWOT分析
    Pro-Pac Packaging Ltd (PPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Strand Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Strand Life Sciences Pvt Ltd (Strand Life) is a healthcare technology company that develops offers bioinformatics and clinical diagnostic software products. The company offers bioinformatics software for most analytics platforms such as microarrays, mass spectrometry, next generation sequenc …
  • Steris Plc (STE):企業の財務・戦略的SWOT分析
    Steris Plc (STE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Florida Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Florida Power & Light Company (FPL), a subsidiary of NextEra Energy, Inc., is a vertically-integrated electric utility that generates, transmits and distributes electricity. The company generates electricity from oil, natural gas, coal, nuclear and solar sources. It also purchases power and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆